High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis.

Lotfi, Amir; Schweiger, Marc J; Giugliano, Gregory R; Murphy, Sabina A; Cannon, Christopher P

Lotfi, Amir; Schweiger, Marc J; Giugliano, Gregory R; Murphy, Sabina A; Cannon, Christopher P.

Affiliation

Lotfi A; Division of Cardiology, Baystate Medical Center, Springfield, MA 01199, USA.

Am Heart J ; 155(5): 954-8, 2008 May.

Article in En | MEDLINE | ID: mdl-18440347

Subject(s)

Acute Coronary Syndrome/drug therapy; Heptanoic Acids/administration & dosage; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage; Platelet Aggregation Inhibitors/administration & dosage; Pyrroles/administration & dosage; Ticlopidine/analogs & derivatives; Aged; Atorvastatin; Clopidogrel; Cytochrome P-450 Enzyme System/physiology; Female; Humans; Male; Middle Aged; Ticlopidine/administration & dosage; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Ticlopidine / Platelet Aggregation Inhibitors / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Acute Coronary Syndrome / Heptanoic Acids Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am Heart J Year: 2008 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google